Genmab — November 2023
-
small new Epco trial by City of Hope Medical Center - Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma https://clinicaltrials.gov/study/NCT06112847
-
and a small new PhI/II Study of Amivantamab and Tepotinib Combo in MET-altered Non-small Cell Lung Cancer. https://clinicaltrials.gov/study/NCT06083857
-
Genmab Announces Multiple Abstracts to be Presented at the 65th Annual Meeting and Exposition of the American Society of Hematology (ASH) https://ir.genmab.com/news-releases/news-release-details/genmab-announces-multiple-abstracts-be-presented-65th-annual
-
ASH23 438 Subcutaneous Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma from EPCORE NHL-5 https://ash.confex.com/ash/2023/webprogram/Paper180089.html
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
-CD38) also accepted